Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Total Current Liabilities (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Total Current Liabilities for 8 consecutive years, with $984.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 0.7% to $984.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $984.5 million, a 0.7% increase, with the full-year FY2025 number at $984.5 million, up 0.7% from a year prior.
  • Total Current Liabilities was $984.5 million for Q4 2025 at Select Medical Holdings, up from $939.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $1.5 billion in Q1 2021 to a low of $939.0 million in Q2 2025.
  • A 5-year average of $1.2 billion and a median of $1.2 billion in 2022 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: surged 82.5% in 2021, then dropped 25.3% in 2025.
  • Select Medical Holdings' Total Current Liabilities stood at $1.3 billion in 2021, then fell by 9.26% to $1.2 billion in 2022, then rose by 8.08% to $1.2 billion in 2023, then fell by 21.69% to $977.7 million in 2024, then rose by 0.7% to $984.5 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Total Current Liabilities are $984.5 million (Q4 2025), $939.6 million (Q3 2025), and $939.0 million (Q2 2025).